396 A Phase I, Dose-finding Study of BI 853520, a Potent...

396 A Phase I, Dose-finding Study of BI 853520, a Potent and Selective Inhibitor of Protein Tyrosine Kinase 2 in Patients with Advanced or Metastatic Solid Tumors

de Jonge, M., Sahebjam, S., Mathijssen, R.H., Razak, A., van der Biessen, D., Pronk, L.C., Schnell, D., Siu, L.L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
48
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(12)72194-9
Date:
November, 2012
File:
PDF, 79 KB
english, 2012
Conversion to is in progress
Conversion to is failed